The US Food and Drug Administration (FDA) on Tuesday released new draft guidance clarifying how it plans to determine cases when real-world data may be sufficient for use in premarket and postmarket ...
Real-World Data (RWD) has become one of the most widely discussed topics across the global medtech sector. But what is driving this increased attention? In reality, collecting data from clinicians and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results